Early Stage Patent Litigation Strategy: The First 90 Days

This interactive session walks attendees through the critical early-stage decisions that shape pharmaceutical and biotech patent litigation long before trial or settlement discussions begin. Using realistic case studies, panellists will react in real time to litigation and business pressures, allowing the audience to benchmark their own instincts against experienced in-house and outside counsel perspectives.

• How companies decide where to litigate first (district court, PTAB, ITC, or parallel paths).
• Early forum strategy trade-offs, including cost, speed, and leverage.
• What evidence must be preserved immediately - and what is often missed.
• How early litigation decisions affect settlement leverage, investor messaging, and payer dynamics.